Its role as an adjunct to conventional criteria could be particularly useful in challenging cases such as early‐stage SNN, CANVAS/RFC1‐neuropathy, and atypical CIDP presentations. This evidence concerns the gene RFC1 and chronic inflammatory demyelinating polyradiculoneuropathy.